Katalog der Deutschen Nationalbibliothek

Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients

Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study

Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation

Using advanced CRISPR-Cas9 functional genetics to model and probe T cell acute lymphoblastic leukemia (T-ALL)

Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia

In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blasts

In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blasts

Palbociclib in acute leukemias with KMT2A-rearrangement: results of AMLSG 23-14 trial

Prädiktive Faktoren für messbare Resterkrankung (MRD) nach Chemotherapie bei Patienten mit AML

Stress-dependent redistribution and nuclear functions of Drosophila AGO1

Stress-dependent redistribution and nuclear functions of Drosophila AGO1

[Band].

Stress-dependent redistribution and nuclear functions of Drosophila AGO1

[CD-ROM].

Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy

Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial

Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial

P448: Prognostic impact of somatic CEBPA BZIP domain mutations in acute myeloid leukemia

Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia

Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial

Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results

Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results

Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy

Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia

Deciphering the oncogenic network of PRC2 loss guided leukemogenesis

Discovery of functional long noncoding RNA loci in acute myeloid leukemia using CRISPR/Cas9 technologies

Genetic dependencies in acute myeloid leukemia revealed by a functional in vivo screening

Identification and functional characterization of novel cervical cancer susceptibility loci

Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia

The E3 ligase itch is a novel positive regulator of mesenchymal stem cells

Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation

KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis

Die prognostische Bedeutung von TP53-Mutationen und dem komplexen Karyotyp bei Patienten mit myelodysplastischem Syndrom oder sekundärer akuter myeloischer Leukämie nach allogener Stammzelltransplantation

Einfluss von Calreticulin-Mutationen auf die Prognose von Patienten mit Myelofibrose nach allogener Stammzelltransplantation

Generation of therapeutically effective stem cell transplants by targeted genome modification

KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial

Functional analysis of the leukemic evolution in children with Down syndrome utilizing CRISPR-Cas9 genome editing

Klinische und prognostische Bedeutung von Mutationen in den Genen SMC3, SMC1A und RAD21 des Cohesin Komplexes bei der akuten myeloischen Leukämie

IDH-Inhibitoren

Differenzierung von AML-Zellen und deren Expressionsanalyse hinsichtlich langer nicht-kodierender RNA

Prognostische und funktionelle Bedeutung des MN1-Onkogens in der akuten myeloischen Leukämie

Reproduzierbare Quantifizierung der Zytostatikaempfindlichkeit menschlicher Tumorzelllinien durch Beseitigung photochemischer Artefakte